LG CNS to Showcase Pharmaceutical AI Solution at CPHI Milan
LG CNS will present its Manufacturing AX solution tailored for the pharmaceutical industry at CPHI Milan 2026. The company aims to expand the reach of its autonomous factory solutions within the pharmaceutical sector.

LG CNS, an IT services provider, is set to showcase its specialized Manufacturing AX (Artificial Experience) solution for the pharmaceutical industry at CPHI Milan 2026, the world's largest exhibition for the pharma and biotech sectors. The presentation will focus on optimizing factory planning, production operations, and quality management.
Operating under the theme “Autonomous Factory in the Pharmaceutical Industry,” LG CNS intends to highlight the benefits of its AI-driven platform. The solution is designed to enhance the efficiency and safety of pharmaceutical manufacturing processes through data-driven decision-making and automation.
The company's participation in CPHI Milan signifies its commitment to strengthening its presence in the global pharmaceutical market. The event serves as a venue to connect with potential clients and partners, emphasizing technological advancements in industrial AI.
LG CNS's Manufacturing AX solution integrates artificial intelligence and advanced analytics to support the entire pharmaceutical manufacturing value chain. This includes factory design simulation, real-time production monitoring, and ensuring adherence to stringent quality standards.